HIOCX
Price
$20.20
Change
-$0.06 (-0.30%)
Updated
Sep 11 closing price
Net Assets
4.04B
VDVIX
Price
$18.10
Change
+$0.17 (+0.95%)
Updated
Sep 11 closing price
Net Assets
323.82B
Interact to see
Advertisement

HIOCX vs VDVIX

HIOCX vs VDVIX Comparison Chart in %
View a ticker or compare two or three
VS
HIOCX vs. VDVIX commentary
Sep 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HIOCX is a Buy and VDVIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VDVIX has more cash in the bank: 324B vs. HIOCX (4.04B). VDVIX pays higher dividends than HIOCX: VDVIX (2.37) vs HIOCX (0.68). HIOCX was incepted earlier than VDVIX: HIOCX (28 years) vs VDVIX (13 years). HIOCX (1.86) is less costly to investors than VDVIX (0.16). HIOCX is a more actively managed with annual turnover of: 46.00 vs. VDVIX (4.00). VDVIX has a lower initial minimum investment than HIOCX: VDVIX (0) vs HIOCX (2000). VDVIX annual gain was more profitable for investors over the last year : 21.95 vs. HIOCX (7.40). VDVIX return over 5 years is better than : 41.64 vs. HIOCX (12.57).
HIOCXVDVIXHIOCX / VDVIX
Total Expense Ratio1.860.161,163%
Annual Report Gross Expense Ratio1.860.161,163%
Fund Existence28 years13 years-
Gain YTD10.38316.72262%
Front LoadN/AN/A-
Min. Initial Investment20000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.04B324B1%
Annual Yield % from dividends0.682.3729%
Returns for 1 year7.4021.9534%
Returns for 3 years50.5063.4880%
Returns for 5 years12.5741.6430%
Returns for 10 years68.35110.4262%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GMXRX16.310.14
+0.87%
Nationwide Mid Cap Market Idx R
VGSNX20.800.16
+0.78%
Vanguard Real Estate Index Institutional
AVEEX18.170.12
+0.66%
Avantis® Emerging Markets Equity Instl
FRVFX52.910.25
+0.47%
Franklin Small Cap Value C
RYCFX53.220.09
+0.17%
Rydex Biotechnology C